ARCHIVES

Caution Advised for Hormone Replacement Therapy

This article is from The Cancer Letter archive.

Vol. 12 No. 12 | March 21, 1986

Download PDF Visit The Full Archive

Related Articles

Aphton To Test Anti-Gastrin Drug At M. D. Anderson. NAS

March 31, 2000

NCAB Approves CIS Recompetition, Restructuring

May 17, 1991

House Committee Seeks Information on ImClone Insider Stock Trading.

March 29, 2002

FDA Approves Arranon For Leukemia And Lymphoma

December 30, 2005

Board Oks Construction PA Fro Breast Cancer Research Facilities

July 9, 1993

Broder’s Conundrum: How To Let Congress Know NCI Needs More Money Without Asking For it

March 17, 1989